Groups Groups
Powered by TakingITGlobal
TakingITGlobal

Home Home Action Tools Groups Global Youth Coalition on HIV/AIDS Messages   
select language: 

Group:
Global Youth Coalition on HIV/AIDS
  Login Sign Up

Information Members Messages Documents Related Items

Message   Message back to messages

From: "Gabriel, ADEYEMO" [ profile ]
Subject: GYCA Members participated at the 2012 IAPAC meeting in London
Sent: Jun 20th, 2012 - 05:42:38

  Fellow GYCA Colleagues


The concepts of antiretroviral-based Treatment as Prevention (TasP) and
Pre-Exposure Prophylaxis (PrEP) gained formidable ground in 2011, both
cited in numerous 2011 Top 10 lists of clinical development in HIV
medicine. In addition, PrEP has recently been a topic of heated debate as
regulatory bodies – most notably the US Food and Drug Administration (FDA)
– entertain approving expanded indications for existing antiretroviral
drugs for HIV prevention.



Last week (June 11th and 12th) 2012, the International Association of
Physicians in AIDS Care (IAPAC), in partnership with the British HIV
Association (BHIVA), hosted a two-day; Controlling the HIV Epidemic with
Antiretrovirals summit with a goal of providing a venue for the
presentation of data related to and discussion about the practical aspects
of TasP and PrEP implementation in a variety of clinical settings.



GYCA of course had good representatives at this meeting. Edmond Atindaana (
atindaana (at) live.com) from Ghana and Gabriel Adeyemo, West Africa RFP both
participate in this meeting in a process to learning more about prevention
sciences and also advocate for young people’s inclusion into Vaccine
development components on HIV/AIDS/STIs.


For both of us, it was another high level meeting to discuss pure research
and vaccine development in the HIV field. Listening to great researchers
and authors in the public health field was wonderful, getting to speak our
mind as a young person at various intervals and mincing with world renowned
scientist was also interesting. One major question that struck our mind was
"If PrEP and TasP are going to become realities therefore, implementation
must be phased and not before substantial health system strengthening. Can
the fact that treatment is now prevention achieve what Universal Access
could not"?


All presentation made at this meeting are available on the IAPACs’ website;
http://www.iapac.org/tasp_prep/index.html And a consensus points were
reached, which will be featured in a statement to be released at the XIX
International AIDS Conference in Washington, DC, USA.


Send email to iapac (at) iapac.org with subject "Consensus Statement" to request
a copy of the Consensus Statement.


Among lessons learnt in this meeting personally was;

- Public health and human rights imperatives in a combination
prevention strategy

- The role of ARVs in prevention; TasP and PrEP

- Challenges that research and implementation often face,

- Intensifying and scale-up ART for those with CD4



TIG Groups is a communications tool provided free of charge by TakingITGlobal. TakingITGlobal is not responsible for the content of group discussions.
[ Terms of Service | Privacy Policy | Report a problem ]